Cargando…

In Response

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Prendergast, B D, Banning, A P, Hall, R J C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal College of Physicians of London 1996
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401505/ https://www.ncbi.nlm.nih.gov/pubmed/30668022

Ejemplares similares

In Response
por: Prendergast, B D, et al.
Publicado: (1997)

Valvular Heart Disease: Recommendations for Investigation and Management: Summary of Guidelines Produced by a Working Group of the British Cardiac Society and the Research Unit of the Royal College of Physicians
por: Prendergast, B D, et al.
Publicado: (1996)

Impact of COVID‐19 on schooling in rural Zimbabwe
por: Piper, Joe D., et al.
Publicado: (2022)

Response to Dr Fried & Dr Kievit, and Dr Malhi et al.
por: Schmaal, L, et al.
Publicado: (2016)

Response
por: Basile, K., et al.
Publicado: (2020)

Response to Belgard et al.
por: Skafidas, E, et al.
Publicado: (2014)

Response to ‘Predicting the diagnosis of autism spectrum disorder using gene pathway analysis'
por: Robinson, E B, et al.
Publicado: (2014)

Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
por: Pardanani, A, et al.
Publicado: (2015)

In Response
por: Edupuganti, Srilatha, et al.
Publicado: (2013)

Response to correspondence concerning: “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”
por: Lammers, A.J.J., et al.
Publicado: (2021)

Response to Kounali et al.'s letter of response
por: White, P. J., et al.
Publicado: (2019)

Response to case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
por: Pouliquen, I. J., et al.
Publicado: (2017)

Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results
por: Hughes, T P, et al.
Publicado: (2017)

In Response
por: Shaw, D A
Publicado: (1997)

Majeed syndrome: description of a novel mutation and therapeutic response to bisphosphonates and IL-1 blockade with anakinra
por: Roy, Noémi B A, et al.
Publicado: (2020)

Authors' Response
por: Wassenaar, E. B., et al.
Publicado: (2008)

Cost analysis for cancer subgroups
por: Hall, P S, et al.
Publicado: (2009)

Response to: Investigating the neurobehavioral symptoms of neuronopathic Hunter syndrome
por: Eisengart, J.B., et al.
Publicado: (2020)

Novel genetic variants linked to coronary artery disease by genome-wide association are not associated with carotid artery intima-media thickness or intermediate risk phenotypes
por: Cunnington, M.S., et al.
Publicado: (2009)

Response to Damiani and colleagues
por: Diehl, J-L, et al.
Publicado: (2020)

Response to: A more appropriate use of antibiotics in COVID-19 infection
por: Pinxt, C M H, et al.
Publicado: (2021)

Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia
por: Collette, Y, et al.
Publicado: (2015)

In Response
por: Suntornsut, Pornpan, et al.
Publicado: (2014)

Development of Rapid Response Plan for Radiation Oncology in Response to Cyberattack
por: Nelson, Carl J., et al.
Publicado: (2020)

Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy
por: Andres, R, et al.
Publicado: (2002)

Novel BRAF alteration in desmoplastic infantile ganglioglioma with response to targeted therapy
por: Blessing, Melissa M., et al.
Publicado: (2018)

Systemic inflammatory response to inhaled endotoxin does not correlate with airway response
por: Sood, Amika K., et al.
Publicado: (2019)

Response to Letter to the Editor on “Digital Orthopedics. A Glimpse Into the Future in the Midst of a Pandemic”
por: Bini, Stefano A., et al.
Publicado: (2020)

A response to letter to the editor: A genetic-based algorithm for personalized resistance training
por: Jones, N, et al.
Publicado: (2016)

It is Important to Examine Physical Functioning and Inflammatory Responses During Post-Hospitalization COVID-19 Recovery
por: McGrath, Ryan, et al.
Publicado: (2021)

Response to Letter to the Editor by Ish et al. entitled ‘COVID-19 vaccine equity—the need of the hour’
por: Maclean, P, et al.
Publicado: (2022)

Response
por: Corral, Juan E., et al.
Publicado: (2020)

Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria
por: Hamaoka, T, et al.
Publicado: (2010)

Response to: Comment on “Cost-Saving Early Diagnosis of Functional Pain in Nonmalignant Pain: A Noninferiority Study of Diagnostic Accuracy”
por: Egloff, N., et al.
Publicado: (2016)

In Response Treating High Blood Pressure Following Acute Stroke
por: Bath, P M W, et al.
Publicado: (1996)

Response to ‘Jangle fallacy epidemic in obesity research: a comment on Ruddock et al. (2017)’
por: Ruddock, H K, et al.
Publicado: (2018)

Disseminated Nocardia infection: spontaneous resolution in response to decrease of immunosuppression
por: van Dijk, K., et al.
Publicado: (2014)

Letter to the Editor response: Nygaard et al.
por: Towfic, F., et al.
Publicado: (2017)

Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents
por: Duchmann, M, et al.
Publicado: (2017)

Response To Letter To The Editor Regarding Article "Repolarization Parameters Are Associated With Mortality In Chagas Disease Patients In The United States"
por: Bradfield, J, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ggah4khk3rero9ujl9lm480dtt